Princeton Pharmatech Earns RapidRatings Gold Badge
Recognized for financial strength and stability.
Recognized for financial strength and stability.
Princeton Pharmatech is proud to announce that we have been awarded the Gold Badge from RapidRatings, a distinction that recognizes outstanding financial health, enterprise resilience, and disciplined operational execution.
This achievement is based on the Financial Health Rating (FHR®)—a rigorous, data-driven assessment used by leading global organizations to evaluate the long-term viability and risk profile of their partners. Gold status is reserved for a select group of companies that demonstrate superior financial performance, stability, and governance.
Earning the RapidRatings Gold Badge reinforces Princeton Pharmatech’s position as a trusted, high-performing partner across the clinical development landscape. It reflects:
As the role of biostatistics and data science continues to expand into strategic decision-making across the development lifecycle, this recognition underscores the foundation that enables us to lead with confidence. Our clients rely on us not only for technical excellence, but for stability, foresight, and partnership continuity.
We view this recognition as both an achievement and an ongoing commitment—to uphold the highest standards of financial and operational performance while continuing to innovate in support of our clients’ most critical programs.
This milestone is a reflection of the dedication of our team and the trust of our partners. We remain focused on delivering excellence at every stage of collaboration.
Pamela Gordon
Chief Operating Officer